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Abstract
In this study, we examined the effects of varying collagen concentration and crosslink 
density on the biological, structural and mechanical properties of collagen-GAG scaffolds 
for bone tissue engineering.  Three different collagen contents (0.25%, 0.5% and 1% 
collagen) and two different dehydrothermal (DHT) crosslinking processes [1] 105°C for 
24 hours and [2] 150°C for 48 hours were investigated. These scaffolds were assessed for 
1) pore size, 2) permeability 3) compressive strength and 4) cell viability. The largest 
pore size, permeability rate, compressive modulus, cell number and cell metabolic 
activity was all found to occur on the 1% collagen scaffold due to its increased collagen 
composition and the DHT treatment at 150°C was found to significantly improve the 
mechanical properties and not to affect cellular number or metabolic activity.  These 
results indicate that doubling the collagen content to 1% and dehydrothermally 
crosslinking the scaffold at 150°C for 48 hours has enhanced mechanical and biological 
properties of the scaffold making it highly attractive for use in bone tissue engineering.
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2Introduction
Tissue engineering (TE) requires 3D porous scaffolds that deliver the appropriate 
mechanical, structural and biological environments for tissue repair and regeneration.
Mechanical, material and biochemical parameters such as pore size, permeability, 
interconnectivity, porosity and scaffold composition all affect cellular response and the 
success of a tissue engineered construct (Freyman et al. 2001; O'Brien et al. 2007; 
O'Brien et al. 2005; Tierney et al. 2008; Zeltinger et al. 2001). In our laboratory, we 
utilize a collagen-glycosaminoglycan (GAG) biological scaffold that has been used in a 
variety of tissue engineering applications including skin (Yannas et al. 1989), peripheral 
nerve (Chamberlain et al. 1998), muscle (Menard et al. 2000) and cartilage (Pfeiffer et al. 
2008). These scaffolds are extremely biocompatible with non-toxic degradation products, 
have a high porosity of ~ 99.5% with an interconnected pore architecture allowing for the 
infiltration of nutrients and subsequent removal of waste products. 
These characteristics make the collagen-GAG scaffold extremely attractive for use in 
bone tissue engineering. An additional advantage of these scaffolds is that the 
microstructural architecture, such as the pore size, can be controlled by varying a number 
of parameters during the fabrication process (O'Brien et al. 2004). The scaffolds are
produced through a lyophilisation or freeze-drying process whereby a suspension of 
collagen and GAG in acetic acid is cooled at a constant rate to a final temperature of 
freezing. O’Brien et al. (2005) found that by varying the final freezing temperatures (Tf = 
-10, -20, -30, -40°C), a range of collagen-GAG scaffolds with varying mean pore sizes
(151, 121, 110, 96µm respectively) could be produced. These scaffolds were then 
3subjected to in vitro cell studies and it was found that pore size significantly affected cell 
attachment with the scaffolds with the smallest mean pore size demonstrating the highest 
levels of attachment.  It was hypothesised that this was due to an increased surface area 
producing a higher ligand density for cells to bind to. Pore size is thus an important 
parameter of tissue-engineered scaffolds as it defines the specific surface area and ligand 
availability that is available for cells to attach to and migrate on. It has been hypothesised 
that pores need to be large enough for cells to migrate into the scaffold, but small enough 
to retain a high specific surface area and many studies have found that cell attachment 
and the corresponding cellular response is affected by pore size (Berry et al. 2004; 
Doillon et al. 1986; O'Brien et al. 2005).
Another intrinsic scaffold property that is linked to pore size and the interconnectivity of 
the pores is permeability. Permeability is an important characteristic of tissue-engineered 
constructs because it allows the diffusion of nutrients and cytokines into the scaffold and 
allows the diffusion of waste products out of the scaffold. It is also an important 
parameter in relation to the biophysical stimuli that cells experience while attached to the 
scaffold (Al-Munajjed et al. 2008; Maroudas et al. 1968; O'Brien et al. 2007). Studies 
have previously shown that a cellular solid modelling technique using a 
tetrakaidecahedral unit cell to represent the pores of collagen-GAG scaffolds can 
accurately represent and predict salient microstructural features such as permeability in 
the collagen-GAG scaffold (Al-Munajjed et al. 2008; Gibson and Ashby 1997; O'Brien et 
al. 2007). This modeling is possible because the pore structure of a variety of low-
density, open-cell foams has been observed to have three consistent features: an average 
4of 14 faces per unit cell, 5.1 edges per face, and vertices that are nearly tetrahedral. The 
tetrakaidecahedron is a polyhedron that packs to fill space, approximates the structural 
features of many experimentally characterised low-density, open-cell foams, nearly 
satisfies the minimum surface energy condition, and is often used for modelling such 
foams.  This model is used in this study to calculate permeability.    
The collagen-GAG scaffold was originally designed and optimised for use in skin 
regeneration (Yannas and Burke 1980) and its composition had not been optimised for 
any other cell phenotype or tissue applications.. In our laboratory, we are interested in 
bone and cartilage tissue engineering and have demonstrated that the collagen-GAG 
scaffold can support mesenchymal stem cell (MSC) differentiation down the osteogenic 
and chondrogenic routes (Even-Ram and Yamada 2005; Farrell et al. 2007; Farrell et al. 
2006; Hubbell 2003; Tierney et al. 2008). A recent study in this laboratory has 
demonstrated that osteoblastic cell behaviour is affected by varying the collagen and 
GAG content in scaffold indicating that scaffold composition plays an important role in 
maintaining cell phenotype and retaining the bioactivity of the collagen-GAG scaffold. 
By doubling the amount of collagen (1%) present in the scaffold relative to the proportion 
found in the skin regeneration template (0.5%), a significant increase in osteoblastic cell 
number and metabolic activity on the collagen-GAG scaffold was found (Tierney et al. 
2008). This is an indicator that tissue engineering scaffolds need to be designed with 
specific cell and tissue applications in mind.    
5The main limitation encountered with the collagen-GAG scaffolds for tissue engineering 
applications is that it has poor mechanical properties, particularly for use in bone tissue 
engineering. The mechanical properties of any scaffold are important in order to facilitate 
applications such as cell culture in vitro, in vivo implantation and mechanical 
functionality once implanted (Harley et al. 2007). Mechanical properties are also 
important for maintaining 3D architecture for cell attachment and cell migration, 
applying biophysical stimuli to cells within the scaffold and mediating adaptive cell 
stiffening due to cell focal adhesions attachment (Bacabac et al. 2008; Klein-Nulend et al. 
2005). The mechanical stiffness of the collagen-GAG scaffold can be increased by 
utilising a crosslinking method such as dehydrothermal crosslinking (DHT) which binds 
adjacent collagen molecules together by forming crosslinks between them. DHT 
crosslinking is a widespread technique for stiffening and stabilising collagen composite 
materials (Gorham et al. 1992; Yannas et al. 1980). It involves subjecting the collagen-
GAG scaffolds to temperatures above 90°C while under a vacuum, creating crosslink 
bonds between the chains of amino acids present in the collagen molecule. Although 
many other crosslinking techniques can be used, DHT crosslinking is a favoured 
treatment since it does not create cytotoxic products and the scaffold is sterilised by the 
high temperatures used. Another recent study in this laboratory has demonstrated that by 
subjecting the collagen-GAG scaffolds to a range of DHT temperatures (T = 105°C,
120°C, 150°C, 180°C).  By varying the process,  a significant increase in compressive 
and tensile modulus ranging from 0.5-1 kPa in compression and 1.9-7.6 kPa in tension 
(Haugh et al. 2008) was found in the scaffolds.
6In this study, we wanted to combine the results from the two studies which demonstrated: 
[1] improved osteoblastic response by altering the collagen and GAG composition 
(Tierney et al. 2008) and [2] improved mechanical properties by DHT crosslinking  
(Haugh et al. 2008) to create an optimised collagen-GAG scaffold that could be used in 
bone tissue engineering. Specifically, we wanted to examine the effect of varying 
collagen concentration and crosslink density on the biological, structural and mechanical 
properties of collagen-GAG scaffolds for bone tissue engineering.  Three different 
collagen contents (0.25%, 0.5% and 1% collagen) and two different crosslinking 
processes [1] 105°C for 24 hours and [2] 150°C for 48 hours were investigated.  The 
former crosslinking process is used in the skin regeneration scaffolds  (Yannas and Burke 
1980) and the latter is the optimised process developed in the Haugh et al. study.  These 
scaffolds were assessed for 1) pore size, 2) permeability 3) compressive strength 
(Young’s modulus and 4) cell number and metabolic activity.  
72. Materials and Methods
2.1. Fabrication of the variant collagen-glycosaminoglycan co-polymer scaffolds 
The collagen-glycosaminoglycan (GAG) scaffolds were fabricated using a previously 
described freeze-drying technique by O’Brien et al (O'Brien et al. 2004). The collagen-
GAG slurry was made by combining type I collagen isolated from bovine tendon (Integra 
Lifesciences, Plainsboro, NJ) with chondroitin-6-sulphate isolated from shark cartilage 
(Sigma-Aldrich, Germany) in a 0.05M glacial acetic acid solution. The slurry was 
blended together at 15,000 rpm using an overhead blender (Ultra Turrax T18, IKA Works 
Inc., Wilmington, NC). The suspension was maintained at 4°C using a cooling system 
(WKL 230, Lauda, Germany) to prevent denaturation of the collagen fibers as a result of 
the heat generated by mixing. The resulting suspension was degassed to remove any air 
bubbles and subsequently stored at 4°C. The slurry was freeze-dried using a constant 
cooling technique (O'Brien et al. 2004). 67.25ml of the collagen-GAG slurry was 
pippetted into a stainless steel pan (5 x 5, grade 304 SS). The tray was placed onto the 
shelf of the freeze-dryer (Advantage EL, VirTis Co., Gardiner, NY) and cooled to -40°C 
at 0.9°C/min. Previous work found that this freezing protocol produced scaffolds with a 
mean pore size of 96µm in the collagen-GAG scaffolds containing 0.5% collagen and 
0.044% chondroitin-6-sulphate. A range of collagen-GAG scaffolds was fabricated by 
altering the quantity of collagen in solution with respect to the standard (skin 
regeneration) collagen composition as previously described (Tierney et al. 2008). Briefly,
the standard collagen-GAG scaffold contains 3.6g of collagen (0.5% w/v solution) and 
0.32g of chondroitin-6-sulphate (0.044% w/v solution). Three groups of collagen-GAG 
8scaffolds were fabricated containing 0.25%, 0.5% (Standard) and 1% collagen while the 
amount of chondroitin-6-sulphate kept constant at 0.32g.
2.2 Dehydrothermal Crosslinking Treatment
Dehydrothermal treatment (DHT) was carried out by placing the three scaffold groups in 
open aluminium foil packets and placing them inside a vacuum oven (VacuCell 22, 
MMM, Germany) under a vacuum of 0.05 bar. To determine the effect of DHT 
crosslinking on collagen-GAG scaffold variants, the exposure period and crosslinking 
temperature were varied. Two exposure periods were chosen [1] 105°C for 24 hours and 
[2] 150°C for 48 hours. 105°C was chosen as the control crosslinking temperature, while 
150°C for 48 hours has previously been found to significantly increase the tensile and 
compressive moduli of the collagen-GAG scaffolds. These settings were found to give 
the optimal balance between increased mechanical properties and denaturation of the 
collagen fibres (Haugh et al. 2008).  
2.3 Measurement of pore size
To determine the average pore size of the collagen scaffold variants, 9.6mm samples 
were removed from four corner locations of each scaffold. At each location, samples 
were obtained to analyze both the longitudinal and transverse planes of the scaffold. 
These were then embedded in JB-4 glycolmethacrylate, serially sectioned on a microtome
(Leica, Laboratory Instruments and Supplies, Ireland) at a thickness of 5µm, stained 
using 2% toulidine blue and visualized on an optical microscope at 100x magnification 
for all images. These images were analysed using a linear intercept macro written for 
9Scion ImageTM image analysis software (Scion Corp., Frederick, MD). The program 
constructed a best-fit ellipse representing an average pore cross-section for each image 
analysed. The mean intercept length was an average of the major and minor axes of the 
reconstructed best-fit shape of the pore. The mean pore diameter of the scaffolds was 
calculated by the average of the mean intercepts of the transverse and longitudinal planes.
2.4 Mathematical (calculated) permeability
A low-density, open-cell foam cellular solids model utilising a tetrakaidecahedral unit 
according to O’Brien et al (2005, 2007) was used to calculate the mathematical and 
predicated permeability of the collagen-GAG variants. This modeling is possible because 
the pore structure of a variety of low-density, open-cell foams has been observed to have 
three consistent features: an average of 14 faces per unit cell, 5.1 edges per face, and 
vertices that are nearly tetrahedral. These studies have shown that cellular solids 
modelling techniques using the tetrakaidecahedral unit cell to represent the pores of the 
collagen-GAG scaffold can accurately represent and predict salient microstructural 
features such as surface area and permeability. The tetrakaidecahedron is a polyhedron 
that packs to fill space, approximates the structural features of many experimentally 
characterised low-density. Permeability (K) of the collagen scaffolds is described in 
terms of mean pore diameter (d), percentage compression (ε), scaffold relative density 
(ρ*/ρs) and  a dimensionless system constant (A') taken from O’Brien et al (2007). No 
compression of the scaffold was performed (ε = 0), therefore (1 – ε)2 was set as 1. The 
density ρ* was measured for each collagen variant and the relative density (ρ*/ ρs) and 
10
porosity of each of the collagen variants calculated (Table 2.2: data from Tierney et al. 
2008). These values where then imputed into Equation (1) and permeability calculated. 
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2.5 Mechanical Testing 
Unconfined compression testing was used to determine the effect of crosslinking and 
scaffold composition on the mechanical properties of the scaffolds. Testing was carried 
out using a mechanical testing machine (Z050, Zwick/Roell, Germany) fitted with a 5-N 
load cell. Samples of 9.6 mm diameter were cut from the scaffolds using a punch and pre-
hydrated in phosphate buffered saline (PBS) for one hour prior to testing. All testing was 
carried out in a bath of PBS. Testing was conducted at a strain rate of 10%/min. The 
modulus was defined as the slope of a linear fit to the stress-strain curve over 2-5% 
strain.
2.6 Cell Culture  
The scaffolds were subjected to cell culture to assess the effects of collagen content and 
crosslinking density and compared to a control scaffold of 0.5% collagen crosslinked at 
105°C for 24 hours. MC3T3-E1 mouse clonal pre-osteoblastic cells (sourced ATCC, 
LGC, Europe) were cultured in standard tissue culture flasks using α-MEM supplemented 
with 10% fetal bovine serum, 1% L-glutamine and 2% penicillin/streptomycin solution 
(Sigma-Aldrich, Germany). The media was replaced every 3-4 days. Cells were removed 
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from the flasks using a trypsin-EDTA solution (Sigma) and cell number calculated using 
a hemacytometer. The resulting cell solution was centrifuged for 5 min at 20°C and re-
suspended in supplemented media to obtain a cell suspension of 1 x 106 cells per 400µl.  
1 x 2 cm (~ 4 mm in height) were cut from each of the collagen-GAG scaffold variants 
crosslinked at 150°C for 2 days and placed into a 6-well tissue culture plate (Sarstedt Ltd, 
Ireland). Each well was pre-coated with 2% agarose gel (Promega, AGB Scientific Ltd, 
Ireland) to prevent cells from adhering to the tissue culture plate. Each scaffold sample 
was then seeded with 2 x 106 cells. Constructs were maintained at 37°C with 5% CO2
with 4mls of supplemented media in each well. Constructs were evaluated at 24, 48 hours 
and 7 days post-seeding. 
Cell Number Assessment
Cell number was evaluated by culturing the collagen-GAG scaffolds as described above 
for 24, 48 hours and 7 days. After cell culture, samples were flash frozen in liquid 
nitrogen and stored at -80°C till analysis. Samples were then thawed and the matrices 
digested in papain. Cell number was evaluated using Hoechst 33258, which labels double 
stranded DNA fluorescently (Sigma-Aldrich, Germany), according to a previously 
published protocol (Kim et al. 1988). Measurements were taken in triplicate and read at 
355 nm excitation and 460 nm emission using a fluorescence spectrophotometer (Wallac 
Victor2, PerkinElmer Life Sciences). Readings were converted to cell number using a 
standard curve. These experiments were repeated to provide a sample size of n = 4 per 
scaffold variant group for 24 and 48 hours and a sample size of n =7 for 7 days, 
combining the scaffolds used from the alamarBlue assay metabolic assay.  
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Cell Metabolic Activity
Cell metabolic activity was evaluated using alamarBlueTM (Invitrogen, BioSciences, 
Dublin) at 24, 48 hours and 7 days. This assay is a non-endpoint, non-toxic assay that 
measures mitochondrial metabolic activity (O'Brien et al. 2000). Scaffolds were 
transferred to 6-well plates and placed in 4 ml of supplemented media α-MEM containing 
10% alamarBlueTM. Plates were placed on an orbital shaker (Biosan, Riga, Latvia) in the 
incubator at 37°C with 5% CO2. After 2.5 hours, 100µl of the supernatant was plated out 
in triplicate into a 96-well plate and the absorbance read on a spectrometer (Titertrek 
MultiScan, MSC, Ireland) at 540nm and 620nm. Percentage reduction of the alamarBlue 
solution was determined according to the manufacturers’ specifications. These 
experiments were repeated to provide a sample size of 7 scaffolds per scaffold variant 
group. Scaffolds were flash frozen with liquid nitrogen and stored at -80°C and used for 
cell number analysis.
2.7 Statistical Analysis
Results are expressed as mean + standard deviation. One-way analysis of variance 
(ANOVA) followed by multiple comparisons procedures (Holm-Sidak) was used to 
evaluate the effects of collagen concentration and DHT temperature on mean pore size
and compressive modulus. Two-way repeated measures analysis of variance (RM-
ANOVA) followed by multiple comparisons procedures (Holm-Sidak) was used to 
evaluate the effect of collagen concentration and culture duration on cell number and 
metabolic activity. Statistical significance was declared at p <0.05.   
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3. Results
3.1 Pore Structure
The smallest pore size was found both on the 0.25% collagen variants crosslinked at the 
two different temperatures. A mean pore size of 58µm was found on the 105ºC DHT with 
a slight increase to a mean of 81µm found on the 150ºC DHT as shown in Table 1. The 
0.5% collagen pore sizes correlated well with existing data with the mean being measured 
at 93µm and 95µm for the 105ºC and 150ºC DHT respectively. The largest pore size was 
found on the 1% collagen scaffold with a mean 112µm on the 105ºC DHT and a mean of 
106µm on the 150ºC DHT (Fig 2). These 1% collagen scaffolds had a significantly larger
pore diameter compared to the other two scaffold groups (p = 0.009) (Fig.1).
3.2 Calculated Permeability
The mathematically calculated permeability values are shown in Table 2. Scaffolds with 
larger pore sizes displayed increased permeability.  The 1% collagen scaffold DHT at 
105°C experiences the highest permeability value at 0.758 x 10-10 m4/Ns with lowest
permeability experienced by the 0.25% collagen variant at 0.203 x 10-10 m4/Ns (mean 
pore size 58 µm). 
3.3 Compressive Modulus
Compressive modulus increased with increasing collagen content and with increased 
extent of crosslinking (Fig 3). The highest compressive modulus measured was on the 1% 
collagen scaffold at 150ºC DHT which was measured as 3kPa + 0.94 (p< 0.001). This is a 
14
3.8-fold increase compared to the modulus of the 1% collagen at a DHT temperature of 
105ºC.  
3.4 Cell Number
Statistical analysis indicated that collagen concentration had an effect on cell number (p< 
0.001) but culture duration did not (p = 0.118) (Fig 4). The 1% collagen scaffold DHT at 
150°C had a higher cell number across all time points when compared to the other 
scaffold groups including the control (p< 0.001). Crosslinking temperature was found not 
to have an effect on cell number (p = 0.349). 
3.5 Cell Metabolic Activity
For the collagen scaffold variants, the RM two-way ANOVA indicated that both collagen 
concentration (p< 0.001) and culture duration (p< 0.001) had an effect on cell metabolic 
activity. The 1% collagen scaffold experienced the highest metabolic activity over all 
time points when compared to the other scaffold groups (p< 0.001) and there is a 
significantly higher metabolic activity on the scaffolds at day 7 when compared to 24 
hours (p = 0.025) (Fig 5). Crosslinking temperature was found not to have an effect on 
cellular behaviour (p = 0.723)
15
4. Discussion
Scaffolds for tissue engineering such as the collagen-GAG scaffold must encompass a set 
of parameters that facilitate cellular adhesion, migration and tissue formation. These 
include a sufficient, interconnected pore structure to allow cell migration into the 
scaffold, cell attachment, adequate diffusion of nutrients in and waste products out of the 
scaffold and sufficient mechanical stability to provide functionality of the scaffold in 
vitro and in vivo (Even-Ram and Yamada 2005; Harley and Gibson 2007; O'Brien et al. 
2005; Zeltinger et al. 2001).  The aim of this study was to create an optimal collagen-
GAG scaffold for bone tissue engineering by combining the optimum composition for 
osteoblast attachment (Tierney et al. 2008) with the optimised mechanical properties
(Haugh et al. 2008).  The collagen-GAG scaffolds were fabricated into groups containing 
0.25%, 0.5% and 1% collagen with the amount of chondroitin-6-sulphate kept constant. 
These were then dehydrothermally crosslinked at 105°C and 150°C to increase 
mechanical integrity and the resultant mechanical, structural and biological properties 
were then measured.
The size of the pores in the collagen-GAG scaffold is controlled by the rate of ice 
nucleation during the cooling process and the consequent sublimation of ice crystals
(O'Brien et al. 2004). The 1% collagen scaffold had a significantly larger mean pore 
diameter compared to the other two scaffold groups (p = 0.009) with pore size measured 
at 112µm and 106µm for the 105°C and 150°C DHT groups respectively (Fig 1 and Fig 
2). The smallest pore size measured was found on the scaffold containing the least 
amount of collagen, the 0.25% scaffold measuring at 58µm with a slight increase in pore 
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diameter to 81µm on the 0.25% scaffold DHT at 150°C. This small diameter of pore size 
can be attributed to the weak mechanical properties of the 0.25% collagen scaffold which 
undergoes a loss of 3D structural integrity due to pore collapse.  The pore size of the 
0.5% collagen scaffold corroborated well with the currently reported pore size of 96µm
(O'Brien et al. 2004), with our scaffolds measuring 93µm and 95µm for the 105°C and 
150°C DHT groups respectively. In general, pore size was found to increase with 
collagen content. Increased collagen content will promote ice crystal nucleation and raise 
the freezing temperature of the collagen slurry. Ice crystal size has previously been 
shown to be proportional to the freezing temperature, explaining the increase in pore size 
(which mirrors ice crystal structure) with increasing collagen content (Searles et al. 
2000).
Cellular solids modelling allows the calculation of permeability of the collagen-GAG 
scaffolds (Gibson and Ashby 1997; O'Brien et al. 2007). Pore size, porosity, 
interconnectivity as well chemical composition of scaffolds can all influence 
permeability. The results show that permeability of the collagen scaffolds increases with 
increasing pore size and increasing collagen content, with the 1% collagen scaffold 
exhibiting the highest permeability rate of 0.758 x 10-10 m4/Ns (Table 2). This rate of 
permeability is a reasonable value for a TE scaffold when you account for the increased 
collagen composition of the scaffold and when compared against lower permeability rates 
of tissues such as cartilage (10-15 m4/Ns) but which is still several orders below that of 
trabecular bone (10-6 m4/Ns) (O'Brien et al. 2007). This value correlates well with 
published literature of permeability of collagen-GAG scaffolds where the experimentally 
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derived permeability value of a collagen-GAG scaffold with a pore size of 110µm is 
0.714 x 10-10 m4/Ns for the 0.5% collagen scaffold at 0% compression (O'Brien et al. 
2007). This is important for nutrient diffusion and waste removal, biophysical stimuli due 
to fluid flow exchanges during mechanical loading and permeability can also affect the
degradation rate of biological scaffolds. The 0.25% collagen scaffold experienced the 
lowest permeability of 0.203 x 10-10 m4/Ns due its smaller mean pore diameter of 58µm.
The compressive moduli of the collagen scaffolds were considerably altered with both 
collagen content and crosslinking temperature (Fig 3). The 1% collagen scaffold
crosslinked at 150°C exhibited the highest compressive modulus of 3kPa + 0.94 and this 
was significantly higher compared to all other groups at both DHT temperatures (p < 
0.001). This is a 3.8-fold increase in stiffness compared to the 1% collagen scaffold 
crosslinked at 105°C, indicating that DHT crosslinking temperature noticeably alters the 
mechanical integrity of collagen-GAG scaffolds. These results indicate that DHT is a 
feasible method for improving the mechanical properties of the scaffolds and can allow 
the production of collagen-GAG scaffolds with a range of mechanical properties and 
compositions depending on the tissue being engineered. The 0.25% collagen scaffold had 
the weakest compressive modulus at 0.317 kPa for both 105°C and 150°C DHT 
temperatures, indicating the weak 3D mechanical integrity of the scaffold due to the 
limited amount of crosslink sites available.  Crosslinks are formed between carboxyl and 
amino groups of the adjacent collagen molecules and the weak modulus can be explained 
by the limited amount of functional crosslinks available in the 0.25% collagen scaffold.   
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The changes in composition, architecture and mechanical properties were found to 
significantly affect cellular behaviour. Increasing the DHT temperature and exposure 
periods of crosslinking leads to a change in the triple helical structure of the collagen 
molecule to a more random chain structure potentially affecting cellular activity (Haugh 
et al. 2008; Pieper et al. 1999; Yunoki et al. 2003) Cell culture results show that collagen 
composition had an effect on cell number over time (p < 0.001), with the 1% collagen 
scaffold having the highest cell number compared to all other groups (Fig 4), emulating 
the results from our previous study (Tierney et al. 2008). It is hypothesised that the 
combined effects of the increased specific surface area provided by the increased 
amounts of collagen, combined with increased mean pore size, and improved 
permeability allows a greater number of cells to attach and proliferate on the 1% collagen 
scaffold accounting for the high cell number measured. Statistical analysis of the 0.5% 
collagen scaffold crosslinked at 150°C and the control 0.5% collagen scaffold DHT at 
105°C, indicates that DHT crosslinking does not have an effect on cell number (p = 
0.349). As increasing the DHT crosslinking temperature to 150°C causes an increase in 
denaturation, from 25% to 41%, these results suggest that the increased level of collagen 
denaturation at 150°C does not affect cell attachment rates or proliferation (Haugh et al. 
2008). Cell metabolic activity was also found to be affected by collagen composition (p< 
0.001), with the 1% collagen scaffold having the highest metabolic activity compared to 
all other groups over time (p< 0.001) (Fig 5). A significant advantage of the collagen-
GAG scaffold is that it is natural polymer and therefore bioactive, allowing osteoblasts to 
maintain high metabolic rates that increase over time and there was a significant increase 
in cell metabolic activity on all collagen scaffolds at 7 days compared to 24 hours (p = 
19
0.025). Again, metabolic activity was not affected by the DHT crosslinking temperature, 
with no statistical difference between the control 0.5% collagen and the 0.5% collagen
DHT crosslinked at 150°C (p = 723). 
In conclusion, these results indicate that doubling the collagen content to 1% and 
dehydrothermally crosslinking the scaffold at 150°C for 48 hours has enhanced 
mechanical and biological properties making it highly attractive for use in bone tissue 
engineering.  The new optimised scaffold has a larger pore size for cell infiltration and 
attachment and increased stiffness for mechanical functionality in vitro and in vivo. The 
increased collagen content to 1% increases both cell number and metabolic activity 
without sacrificing bioactivity of the scaffold as might have been expected due to 
potential denaturation of the collagen molecule at the higher DHT temperatures.
Acknowledgements
This work was funded by the Science Foundation Ireland President of Ireland Young 
Researcher Award (PIYRA). Collagen materials were provided by Integra Life Sciences, 
Inc., through a Materials Transfer Agreement. 
20
References
Al-Munajjed, A. A., M. Hien, R. Kujat, J. P. Gleeson and J. Hammer (2008). "Influence 
of pore size on tensile strength, permeability and porosity of hyaluronan-collagen 
scaffolds." J Mater Sci Mater Med.
Bacabac, R. G., D. Mizuno, C. F. Schmidt, F. C. Mackintosh, J. J. Van Loon, J. Klein-
Nulend and T. H. Smit (2008). "Round versus flat: Bone cell morphology, 
elasticity, and mechanosensing." J Biomech.
Berry, C. C., G. Campbell, A. Spadiccino, M. Robertson and A. S. Curtis (2004). "The 
influence of microscale topography on fibroblast attachment and motility." 
Biomaterials 25(26): 5781-8.
Chamberlain, L. J., I. V. Yannas, H. P. Hsu, G. Strichartz and M. Spector (1998). 
"Collagen-GAG substrate enhances the quality of nerve regeneration through 
collagen tubes up to level of autograft." Exp Neurol 154(2): 315-29.
Doillon, C. J., C. F. Whyne, S. Brandwein and F. H. Silver (1986). "Collagen-based 
wound dressings: control of the pore structure and morphology." J Biomed Mater 
Res 20(8): 1219-28.
Even-Ram, S. and K. M. Yamada (2005). "Cell migration in 3D matrix." Curr Opin Cell 
Biol 17(5): 524-32.
Farrell, E., E. M. Byrne, J. Fischer, F. J. O'Brien, B. C. O'Connell, P. J. Prendergast and 
V. A. Campbell (2007). "A comparison of the osteogenic potential of adult rat 
mesenchymal stem cells cultured in 2-D and on 3-D collagen glycosaminoglycan 
scaffolds." Technol Health Care 15(1): 19-31.
Farrell, E., F. J. O'Brien, P. Doyle, J. Fischer, I. Yannas, B. A. Harley, B. O'Connell, P. J. 
Prendergast and V. A. Campbell (2006). "A collagen-glycosaminoglycan scaffold 
supports adult rat mesenchymal stem cell differentiation along osteogenic and 
chondrogenic routes." Tissue Eng 12(3): 459-68.
Freyman, T. M., I. Yannas and L. Gibson (2001). "Cellular materials as porous scaffolds 
for tissue engineering." Progress in Materials Science 46: 273-282.
Gibson, L. and M. F. Ashby (1997). Cellular Solids - Structure and Properties. London, 
Cambridge University Press.
Gorham, S. D., N. D. Light, A. M. Diamond, M. J. Willins, A. J. Bailey, T. J. Wess and 
N. J. Leslie (1992). "Effect of chemical modifications on the susceptibility of 
collagen to proteolysis. II. Dehydrothermal crosslinking." Int J Biol Macromol
14(3): 129-38.
Harley, B. A. and L. Gibson (2007). "In vivo and in vitro applications of collagen-GAG 
scaffolds." Chemical Engineering Journal.
Harley, B. A., J. H. Leung, E. C. Silva and L. J. Gibson (2007). "Mechanical 
characterization of collagen-glycosaminoglycan scaffolds." Acta Biomater 3(4): 
463-74.
Haugh, M. G., M. J. Jaasma and J. O'Brien F (2008). "The effect of dehydrothermal 
treatment on the mechanical and structural properties of collagen-GAG 
scaffolds." Journal of Biomedical Materials Research: Part A.
Kim, Y. J., R. L. Sah, J. Y. Doong and A. J. Grodzinsky (1988). "Fluorometric assay of 
DNA in cartilage explants using Hoechst 33258." Anal Biochem 174(1): 168-76.
21
Klein-Nulend, J., R. G. Bacabac and M. G. Mullender (2005). "Mechanobiology of bone 
tissue." Pathol Biol (Paris) 53(10): 576-80.
Maroudas, A., P. Bullough, S. A. Swanson and M. A. Freeman (1968). "The permeability 
of articular cartilage." J Bone Joint Surg Br 50(1): 166-77.
Menard, C., S. Mitchell and M. Spector (2000). "Contractile behavior of smooth muscle 
actin-containing osteoblasts in collagen-GAG matrices in vitro: implant-related 
cell contraction." Biomaterials 21(18): 1867-77.
O'Brien, F. J., B. A. Harley, M. A. Waller, I. V. Yannas, L. J. Gibson and P. J. 
Prendergast (2007). "The effect of pore size on permeability and cell attachment 
in collagen scaffolds for tissue engineering." Technol Health Care 15(1): 3-17.
O'Brien, F. J., B. A. Harley, I. V. Yannas and L. Gibson (2004). "Influence of freezing 
rate on pore structure in freeze-dried collagen-GAG scaffolds." Biomaterials
25(6): 1077-86.
O'Brien, F. J., B. A. Harley, I. V. Yannas and L. J. Gibson (2005). "The effect of pore 
size on cell adhesion in collagen-GAG scaffolds." Biomaterials 26(4): 433-41.
O'Brien, J., I. Wilson, T. Orton and F. Pognan (2000). "Investigation of the Alamar Blue 
(resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity." 
Eur J Biochem 267(17): 5421-6.
Pfeiffer, E., S. M. Vickers, E. Frank, A. J. Grodzinsky and M. Spector (2008). "The 
effects of glycosaminoglycan content on the compressive modulus of cartilage 
engineered in type II collagen scaffolds." Osteoarthritis Cartilage.
Pieper, J. S., A. Oosterhof, P. J. Dijkstra, J. H. Veerkamp and T. H. van Kuppevelt 
(1999). "Preparation and characterization of porous crosslinked collagenous 
matrices containing bioavailable chondroitin sulphate." Biomaterials 20(9): 847-
58.
Searles, J. A., J. F. Carpenter and T. W. Randoplh (2000). "Annealing to Optimize the 
Primary Drying Rate, Reduce Freeze-Induced Drying Rate Heterogeneity, and 
Determine Tg in Pharmaceutical Lyophilization." Journal of Pharmaceutical 
Sciences 90(7): 872-887.
Tierney, C. M., M. J. Jaasma and J. O'Brien F (2008). "Osteoblast activity on collagen-
GAG scaffolds is affected by collagen and GAG concentrations." Journal of 
Biomedical Materials Research: Part A.
Yannas, I. V. and J. F. Burke (1980). "Design of an artificial skin. I. Basic design 
principles." J Biomed Mater Res 14(1): 65-81.
Yannas, I. V., J. F. Burke, P. L. Gordon, C. Huang and R. H. Rubenstein (1980). "Design 
of an artificial skin. II. Control of chemical composition." J Biomed Mater Res
14(2): 107-32.
Yannas, I. V., E. Lee, D. P. Orgill, E. M. Skrabut and G. F. Murphy (1989). "Synthesis 
and characterization of a model extracellular matrix that induces partial 
regeneration of adult mammalian skin." Proc Natl Acad Sci U S A 86(3): 933-7.
Yunoki, S., T. Suzuki and M. Takai (2003). "Stabilization of low denaturation 
temperature collagen from fish by physical cross-linking methods." J Biosci 
Bioeng 96(6): 575-7.
Zeltinger, J., J. K. Sherwood, D. A. Graham, R. Mueller and L. G. Griffith (2001). 
"Effect of pore size and void fraction on cellular adhesion, proliferation, and 
matrix deposition." Tissue Eng 7(5): 557-72.
22
Figure Captions
Table 1: Mean Pore Sizes of Collagen-GAG Scaffolds at 105°C and 150°C DHT
Mean pore sizes of the collagen scaffold variants as measured by the linear intercept 
method with the 1% collagen scaffold displaying the highest mean pore size compared to 
the other two groups (p = 0.009). Results expressed as microns (µm) + S.D.
Table 2: Calculated permeability of the collagen-GAG scaffolds 
Permeability (K) of the collagen-GAG scaffolds as a function of their mean pore sizes
and relative density. Units for K are 1 x 10-10 m4/Ns
Table 3: Relative densities and porosity values for collagen-GAG scaffolds
The measured relative densities of the collagen-GAG scaffolds and the porosity values.  
Figure 1: Mean pore diameters of the collagen-GAG scaffolds DHT crosslinked at 105°C 
and 150°C. Pore diameter expressed in microns (µm). The 1% collagen scaffold has the 
highest mean pore size at both DHT temperatures compared to the other 2 collagen 
groups. Error bars represent S.D. * p = 0.009 relative to all other groups.
Figure 2: Micrographs of the collagen-GAG scaffolds to evaluate pore size and 
distribution, visualised using a 100x magnification: (A) 0.25% Collagen DHT 105°C, (B) 
0.5% Collagen DHT 105°C, (C) 1% Collagen DHT 105°C, (D) 0.25% Collagen DHT 
150°C, (E) 0.5% Collagen DHT 150°C, (F) 1% Collagen DHT 150°C
Figure 3: Compressive moduli of the collagen-GAG scaffolds crosslinked at 105°C and 
150°C DHT (n = 10 per scaffold variant and temperature). Results are expressed in kPa 
with the error bars representing S.D. The 1% collagen scaffold showing a 3.8-fold 
increase in compressive modulus compared to all other collagen groups. *p <0.001 
relative to all other groups, including the 1% collagen DHT crosslinked at 105°C.
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Figure 4: Cell number on the collagen-GAG scaffolds. Error bars represent S.D. (n = 4 
for all time points). The 1% collagen scaffold has the highest cell number over all time 
points  compared to the other collagen groups DHT at 150°C and the control DHT at 
105°C . *p <0.001 relative to all other groups
Figure 5: Cell metabolic activity on the collagen-GAG scaffolds. Results are expressed as 
% reduction of the alamarBlueTM solution. Error bars represent S.D. Again, the 1% 
collagen scaffold has the highest metabolic activity over all time points compared to all 
other groups. *p <0.001 relative to all other groups. All collagen scaffolds also 
experienced an increase in metabolic activity at 7 days compared to 24 hours (p = 0.025).
Table 1
                                                105°C                                150°C   
0.25% Collagen                  58.38 µm + 10                            81.31 µm + 17
0.5% Collagen                    92.95 µm + 17                            94.56 µm + 11
1% Collagen                      112.02 µm + 33                          106.92 µm + 8
Table 1
Table 2
     Scaffold                  Mean Pore Size         Kcalc              Mean Pore Size           Kcalc         
                                       105°C, µm                ε = 0%           150°C, µm                 ε = 0%
0.25% Collagen                   58                 0.203 x 10-10               81                  0.397 x 10-10
0.5% Collagen                     93                 0.525 x 10-10                 96                   0.559 x 10-10
1% Collagen                       112                0.758 x 10-10               107                   0.692 x 10-10
Table 2
Table 3
     Scaffold                     Relative Density               % Porosity             
   DHT 105°C                                                                          
0.25% Collagen                    0.010                               98.9 %
          
0.5% Collagen                      0.007                               99.3 %
             
  1% Collagen                       0.011                               98.8 %
Table 3
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